This line of inquiry matters because effective pain relief that does not alter cognition or mood would expand choices for people who need long-term management. Terpenes are widespread in nature and already appear in foods, fragrances, and some health products, which makes their safety profile easier to study than wholly novel drugs. Scientists are now tracing how these molecules act in the nervous system and what doses and delivery methods could work in people.
If terpene-derived treatments move from animal studies to human trials, they could reshape how clinicians think about non-opioid, non-psychoactive options for chronic pain. The next steps will test whether the mouse results hold up in people and whether these compounds can be engineered into reliable, regulated therapies. Read the full article to follow how this line of research could influence recovery, inclusion, and daily life for those living with persistent pain.
Compounds responsible for the aroma of cannabis and many other plants may offer a surprising new way to relieve chronic pain. Researchers found that several cannabis-derived terpenes significantly reduced pain in mouse models of fibromyalgia and post-surgical pain, with one terpene, geraniol, showing especially strong effects. Unlike THC, these compounds are not associated with psychoactive effects, making them a potentially attractive alternative for pain treatment.
